Urology

For prostate, bladder and kidney cancers, BARC offers a wide range of tumor markers and hormone assays required for disease assessment and follow-up. For example, the PCA3 test for risk determination in prostate cancer is routinely performed in our facilities for medical purposes.

Our catalogue also covers cathecholamine metabolites, renal or urinary stones studies, infectious diseases, endocrinology and follow up after graft.